Antares Pharma

Pharmaceutical Manufacturing • Ewing, New Jersey, United States • 51-100 Employees

Company overview

Headquarters	100 Princeton South, Suite 300, Ewing, NJ 08628, US
Phone number	+16093593020
Website	antarespharma.com
NAICS	3254
Employees	51-100
Socials

Key Contacts at Antares Pharma

Raymond G. Taylor

Senior Director Of Managed Care, Trade Relations & Government Pricing At Antares Pharma Inc.

Beth Sawyer

Director, National Accounts

Thomas Garrity

Director And Audit Committee Chair

Antares Pharma Email Formats

Antares Pharma uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@antarespharma.com), used 60% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@antarespharma.com	60%
{first initial}{last name}	jdoe@antarespharma.com	30%
{last name}{last name}	doedoe@antarespharma.com	10%

About Antares Pharma

About Antares Antares Pharma is a specialty pharmaceutical company that combines drug development expertise with proprietary delivery technology to deliver safe and effective medicines. With a goal of improving dosing, reducing side effects, and improving patient compliance and outcomes, our pursuit of innovative therapies strives to positively affects patients’ lives. We focus on self-injection, pharmaceutical products and technologies with emphasis in rheumatology, urology, endocrinology, and neurology. Through innovation, Antares Pharma combines pharmaceutical and medical device knowledge to produce treatment options that best serve our patients, physicians, partners, and stakeholders. Our Mission We at Antares Pharma leverage our pharmaceutical and medical device expertise to develop innovative products that address needs in underserved therapeutic areas. Our relentless pursuit of better therapies that positively affect patient lives inspires our employees to serve our customers and stakeholders every day.

Antares Pharma revenue & valuation

Annual revenue	$184,000,000
Revenue per employee	$2,788,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$588,800,000
Total funding	$35,000,000